Contextualising the benefits and risks of anti-amyloid therapy for patients with Alzheimer disease and their care team
- Author(s)
- Bhalala, OG; Thompson, J; Watson, R; Yassi, N;
- Details
- Publication Year 2024-07-15,Volume 221,Issue #2,Page 78-82
- Journal Title
- Medical Journal of Australia
- Publisher
- Wiley
- Keywords
- Humans; *Alzheimer Disease/drug therapy; *Patient Care Team; Antibodies, Monoclonal, Humanized/therapeutic use/adverse effects; Risk Assessment; Amyloid beta-Peptides; Alzheimer disease; Clinical trials as topic; Dementia; Immunotherapies
- Research Division(s)
- Population Health And Immunity
- PubMed ID
- 38894659
- Publisher's Version
- https://doi.org/10.5694/mja2.52359
- Open Access at Publisher's Site
https://doi.org/0.5694/mja2.52359- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-06-24 11:29:46
Last Modified: 2024-07-26 09:30:23